-+ 0.00%
-+ 0.00%
-+ 0.00%

*Ovid Therapeutics: Norrett Most Recently Served as Chief Business Officer at Soleno Therapeutics, Where He Led Company's Acquisition by Neurocrine Biosciences >OVID

Dow Jones·07/08/2026 11:15:00

Please log in to view news